Clinic of Cardiovascular and Transplant Surgery, 256420Clinical Center Niš, Niš, Serbia.
Department for Cardiac Surgery, Clinic for Anaesthesiology and Intensive Therapy, 256420Clinical Center Niš, Niš, Serbia.
Vasc Endovascular Surg. 2021 Jul;55(5):461-466. doi: 10.1177/1538574421995321. Epub 2021 Feb 24.
The soluble urokinase-type plasminogen activator receptor (suPAR) in uPAR soluble form is produced when the uPAR is cleaved from the cell membrane during the inflammatory process. Postoperative atrial fibrillation (AF) is the most common perioperative cardiac arrhythmia. It is speculated that elevated suPAR has a role in the development of AF. The aim of our study was to investigate the predictive role of preoperative suPAR in the occurrence of AF during the first 6 months after major vascular surgery.
We included 119 male and 63 female patients with an average age of 67.19 ± 6.02 years, without permanent/persistent AF. Basic predictive model (BASIC) included traditional risk factors for AF: age, gender, body mass index-BMI, smoking status, presence of arterial hypertension, diabetes mellitus and dyslipidemia.
Over the 6-month period, 19 (10.4%) patients had one new episode of atrial fibrillation and 2 patients (1.1%) had 2 episodes of paroxysmal atrial fibrillation. Paroxysms of AF were significantly more frequent in patients who had a resection of an abdominal aneurysm than in patients with other types of major vascular surgery. BASIC had good discriminatory ability in the prediction of AF paroxysms during the first 6 months after surgery (AUC = 0.715, 95%CI 0.590-0.840). Adding suPAR to the basic model significantly improved the discriminative ability of the predictive model for AF episodes (ΔAUC = 0.238, p < 0.001). The predictive performance of the model BASIC+CRP+suPAR, measured using AUC, NRI and IDI statistics, was very similar to the model BASIC+suPAR.
AF is a common complication in surgical patients with high mortality and morbidity. suPAR could improve the ability of traditional risk factors to predict its occurrence up to 6 months after major vascular surgery.
尿激酶型纤溶酶原激活物受体(uPAR)可溶性形式的可溶性尿激酶型纤溶酶原激活物受体(suPAR)是在炎症过程中 uPAR 从细胞膜上裂解时产生的。术后心房颤动(AF)是最常见的围手术期心脏心律失常。据推测,升高的 suPAR 在 AF 的发展中起作用。我们的研究目的是探讨术前 suPAR 在大血管手术后 6 个月内发生 AF 的预测作用。
我们纳入了 119 名男性和 63 名女性患者,平均年龄为 67.19 ± 6.02 岁,无永久性/持续性 AF。基本预测模型(BASIC)包括 AF 的传统危险因素:年龄、性别、体重指数-BMI、吸烟状况、动脉高血压、糖尿病和血脂异常的存在。
在 6 个月期间,有 19 名(10.4%)患者出现了 1 次新的心房颤动发作,有 2 名患者(1.1%)出现了 2 次阵发性心房颤动发作。在接受腹主动脉瘤切除术的患者中,AF 阵发性发作的频率明显高于接受其他类型大血管手术的患者。BASIC 在预测术后 6 个月内 AF 阵发性发作方面具有良好的区分能力(AUC=0.715,95%CI 0.590-0.840)。将 suPAR 添加到基本模型中可显著提高预测模型对 AF 发作的区分能力(ΔAUC=0.238,p<0.001)。使用 AUC、NRI 和 IDI 统计数据衡量的模型 BASIC+CRP+suPAR 的预测性能与模型 BASIC+suPAR 非常相似。
AF 是外科患者常见的并发症,具有较高的死亡率和发病率。suPAR 可以提高传统危险因素预测术后 6 个月内 AF 发生的能力。